Advertisement
Screener

Penumbra, Inc (PEN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

3.1 / 5 stars · 74/120 Roast Me

Penumbra, Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 55.22K shares, a 69.70% decline year-over-year.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 65.93K shares, a 10.40% decline year-over-year.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 125.13K shares, a 349.53% increase year-over-year.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 62.72K shares, a 47.91% increase year-over-year.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 512.09K shares, a 556.89% increase from fiscal 2024.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 77.96K shares, a 67.44% decline from fiscal 2023.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 239.40K shares, a 22.53% decline from fiscal 2022.
  • Penumbra, Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 309.00K shares, a 5.22% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2025-12-31512.09K shares
10-K · filed 2026-02-25
2024-12-3177.96K shares
10-K · filed 2025-02-18
2023-12-31239.40K shares
10-K · filed 2024-02-22
2022-12-3155.22K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
309.00K shares
10-K · filed 2023-02-23
2022-09-3065.93K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
435.99K shares
derived: sum of 4 quarters · filed 2022-11-03
2022-06-30125.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
443.64K shares
derived: sum of 4 quarters · filed 2022-08-05
2022-03-3162.72K shares
10-Q · filed 2022-05-03
346.35K shares
derived: sum of 4 quarters · filed 2022-05-03
2021-12-31182.21K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
326.03K shares
10-K · filed 2022-02-22
2021-09-3073.58K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
201.21K shares
derived: sum of 4 quarters · filed 2021-11-03
2021-06-3027.84K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
347.36K shares
derived: sum of 4 quarters · filed 2021-08-09
2021-03-3142.41K shares
10-Q · filed 2021-05-04
357.59K shares
derived: sum of 4 quarters · filed 2021-05-04
2020-12-3157.39K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
358.10K shares
10-K · filed 2021-02-23
2020-09-30219.73K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02
333.58K shares
derived: sum of 4 quarters · filed 2020-11-02
2020-06-3038.07K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03
207.35K shares
derived: sum of 4 quarters · filed 2020-08-03
2020-03-3142.91K shares
10-Q · filed 2020-05-07
267.89K shares
derived: sum of 4 quarters · filed 2020-05-07
2019-12-3132.87K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
314.43K shares
10-K · filed 2020-02-26
2019-09-3093.50K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
349.45K shares
derived: sum of 4 quarters · filed 2019-11-07
2019-06-3098.61K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
360.11K shares
derived: sum of 4 quarters · filed 2019-08-06
2019-03-3189.45K shares
10-Q · filed 2019-05-07
388.62K shares
derived: sum of 4 quarters · filed 2019-05-07
2018-12-3167.89K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
416.21K shares
10-K · filed 2019-02-26
2018-09-30104.15K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
436.42K shares
derived: sum of 4 quarters · filed 2018-11-05
2018-06-30127.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
467.12K shares
derived: sum of 4 quarters · filed 2018-08-07
2018-03-31117.04K shares
10-Q · filed 2018-05-08
500.51K shares
derived: sum of 4 quarters · filed 2018-05-08
2017-12-3188.10K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
766.93K shares
10-K · filed 2018-02-27
2017-09-30134.85K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
706.57K shares
derived: sum of 4 quarters · filed 2017-11-07
2017-06-30160.51K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
1.15M shares
derived: sum of 4 quarters · filed 2017-08-08
2017-03-31383.46K shares
10-Q · filed 2017-05-09
1.20M shares
derived: sum of 4 quarters · filed 2017-05-09
2016-12-3127.74K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
860.42K shares
10-K · filed 2017-02-28
2016-09-30579.13K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
843.10K shares
derived: sum of 4 quarters · filed 2016-11-03
2016-06-30208.06K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
2016-03-3145.49K shares
10-Q · filed 2016-05-09
2015-12-3110.42K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08
948.87K shares
10-K · filed 2016-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Solventum Corp (SOLV)United States$15.085B9.16
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B